HANGZHOU, China, Nov. 8, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that its 20th Anniversary Ceremony (the "Ceremony") was held in Hangzhou. The Ceremony not only marks a milestone in the Company's history, but also heralds a new chapter for its future growth.
Reflecting on Two Decades of Development
Forging Ahead with Vision and Outlook
The Company will remain steadfast in its effort to integrate pharmacy and healthcare services and continue to explore new frontiers in the field, providing consumers with comprehensive and convenient pharmaceutical and medical solutions.
Unwavering Dedication to Specialized and High-Quality Service
Adapting to the Changing Market Through Service Diversification
Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "Over the past 20 years, Jo-Jo Drugstores has been at the forefront of China's drugstore chains, with an eye on talents cultivation and facilities improvement. At present, considering the current shifts in policies and market, we're actively seeking strategic transformation of business models and expansion of service portfolio. Moving forward, we are dedicated to the continued innovation in practicing our integrated pharmaceutical and medical services, to cater to our increasingly health-conscious consumers. We continue to prioritize our customers and strive to improve our services. We believe that we will keep up with the market trends, sustain our long-term competitiveness in the market and create long-term value for our shareholders."
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.
Forward-Looking Statements
This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
Company Contact:
Frank Zhao
Chief Financial Officer
+86-571-88077108
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1- 646-932-7242
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$2.00 |
Daily Change: | 0.02 1.11 |
Daily Volume: | 925 |
Market Cap: | US$13.310M |
September 26, 2023 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB